Results 11 to 20 of about 4,128,106 (288)

The direct costs of drug-induced skin reactions [PDF]

open access: yesAnnals of Agricultural and Environmental Medicine, 2017
Objective The aim of the study was an assessment of direct costs of patients hospitalised for for skin adverse drug reactions during 2002–2012 in the Department of Dermatology at the Military Institute of Medicine (Ministry of Defence) in Warsaw.
Nina Kiepurska   +4 more
doaj   +3 more sources

The costs of introducing artemisinin-based combination therapy: evidence from district-wide implementation in rural Tanzania [PDF]

open access: yesMalaria Journal, 2008
Background The development of antimalarial drug resistance has led to increasing calls for the introduction of artemisinin-based combination therapy (ACT).
Abdulla Salim   +8 more
doaj   +2 more sources

Drug-cost trajectories after national volume-based procurement in Chinese public hospitals: a 31-province interrupted time-series analysis [PDF]

open access: yesFrontiers in Medicine
BackgroundChina's national volume-based procurement (NVBP) policy reduced prices for selected medicines, but national aggregate drug-cost trends are exposed to concurrent reforms and nonlinear prepolicy trajectories. We assessed public-hospital drug-cost
Jing Mao, Guangqi Liu
doaj   +2 more sources

A systematic review of observational studies evaluating costs of adverse drug reactions

open access: yesClinicoEconomics and Outcomes Research, 2016
Francisco Batel Marques,1,2 Ana Penedones,1,2 Diogo Mendes,1,2 Carlos Alves,1,2 1CHAD – Centre for Health Technology Assessment and Drug Research, AIBILI – Association for Innovation and Biomedical Research on Light and Image, 2School of ...
Batel Marques F   +3 more
doaj   +1 more source

Outcome Measurements in Economic Evaluations of Drug Misuse Interventions [PDF]

open access: yes, 2010
This thesis critically evaluates the measurement of outcomes in economic evaluations of drug misuse interventions. Three different aspects of measuring outcomes are examined: one focusing on non-monetary outcomes at the individual patient level; one ...
Chang, Ching-Wen
core   +4 more sources

Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England. [PDF]

open access: yes, 2008
BACKGROUND: Injection site infections among injecting drug users (IDUs) have been associated with serious morbidity and health service costs in North America.
Ncube, F   +14 more
core   +1 more source

The contribution of drug import to the cost of tuberculosis treatment: A cost analysis of longer, shorter, and short drug regimens for Karakalpakstan, Uzbekistan.

open access: yesPLOS Global Public Health, 2022
Tuberculosis (TB) programs depend on a continuous supply of large amounts of high-quality TB drugs. When TB programs procure TB drugs from international suppliers, such as the Global Drug Facility, they can incur import costs for international transport,
Stefan Kohler   +3 more
doaj   +2 more sources

Willingness to pay for treatment with highly active antiretroviral (HAART) drugs: a rural case study in Cameroon

open access: yesSAHARA-J, 2004
This paper reports on the willingness of HIV/AIDS patients to pay for the most affordable triple therapy combination of antiretrovirals in a local setting in Cameroon.
Kenneth Ngwambokong Muko   +5 more
doaj   +1 more source

Value‐based pricing: Toward achieving a balance between individual and population gains in health benefits

open access: yesCancer Medicine, 2020
Objectives Value‐based pricing of oncology drugs provides a best estimate for the price of a drug, as it relates to the benefits it provides for individual patients. To date, the impact of value‐based pricing to reference cost‐effectiveness thresholds (λ)
Ambica Parmar   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy